- Home
- MCHP vs BDX Comparison
MCHP vs BDX Comparison
Compare MCHP & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MCHP | BDX |
|---|---|---|
| Founded | 1989 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.1B | 48.2B |
| IPO Year | 2004 | 1998 |
Fundamental Metrics
Financial Performance| Metric | MCHP | BDX |
|---|---|---|
| Price | $80.88 | $180.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 26 | 14 |
| Target Price | $107.84 | ★ $196.50 |
| AVG Volume (30 Days) | ★ 7.0M | 1.5M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | 2.23% | ★ 2.33% |
| EPS Growth | ★ 2300.00 | N/A |
| EPS | 0.37 | ★ 1.59 |
| Revenue | $5,349,500,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $35.72 | N/A |
| Revenue Next Year | $16.21 | $2.39 |
| P/E Ratio | $220.01 | ★ $113.43 |
| Revenue Growth | ★ 34.38 | 8.24 |
| 52 Week Low | $48.52 | $140.11 |
| 52 Week High | $105.91 | $213.08 |
Technical Indicators
Market Signals| Indicator | MCHP | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 61.89 | 48.93 |
| Support Level | $70.68 | $175.20 |
| Resistance Level | $82.39 | $186.99 |
| Average True Range (ATR) | 2.30 | 3.80 |
| MACD | 0.95 | -0.54 |
| Stochastic Oscillator | 87.51 | 39.18 |
Price Performance
Historical ComparisonAbout MCHP Microchip Technology Incorporated
Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
About BDX Becton Dickinson and Company
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.